Aberrant expression of CORO1C has been reported in several types of human cancers, e.g., glioblastoma, hepatocellular cancer, breast cancer, non-small cell lung cancer, gastric cancer, and colorectal cancer [31,32,33,34,35,36,37,38]. Here, CORO1C is linked to gastric cancer.